Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 1, 1998, Pages 31-34

  Drotar, Dawn E ^a   Davis, E Elizabeth ^a   Cockcroft, Donald W ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; METHACHOLINE; PLACEBO; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031886158     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62935-3     Document Type: Article

References (21)

1. Johnson M. Pharmacology of long-acting beta-agonists. Ann Allergy Asthma Immunol 1995;75:177-9.
2. Palmer JBD, Rickard KE, Thomson JR. Risks of salmeterol [Letter]. N Engl J Med 1994;331:1314.
3. Boulet LP. Long vs. short-acting beta-agonists: implications for drug therapy. Drugs 1994;47:207-22.
4. Cheung D, Timmers MC, Zwinderman AH, et al. Long-term effects of a long-acting beta, adrenoceptor agonist, salmeterol, on airway responsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-203.
5. Bhagat R, Kalra S, Swystun V, Cockcroft D. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1995;108:1235-9.
6. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996;109:953-6.
7. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7: 235-43.
8. O'Connor BJ, Aikman SL, Barnes PJ. Tolerance to the nonbronchodilator effects of inhaled beta-agonists in asthma. N Engl J Med 1992;327: 1204-8.
9. Cockcroft DW, McParland CP, Britto SA, et al. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-7.
10. 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995;152:1485-9.
11. Bhagat R, Swystun VA, Cockcroft DW. Salbutamol-induced increased airway responsiveness to allergen and reduced protection vs. methacholine: dose-response. J Allergy Clin Immunol 1996;97:47-52.
12. Cockcroft DW, O'Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995;96:44-9.
13. Gauvreau GM, Watson RM, Jordana M, et al. Regular inhaled albuterol increases allergen-induced airway responses and airway inflammation in asthmatic subjects. Am J Respir Crit Care Med 1997; in press.
14. 2 agonist salmeterol in mild to moderate asthmatic patients. Thorax 1993;48:1121-4.
15. 2 agonists. Thorax 1996;51:1051-6.
16. Juniper EF, Frith PA, Hargreave FA. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981;36:575-9.
17. Murray AB, Ferguson AC, Morrison B. Airway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1981;68:119-24.
18. Pauwels R, Joos G, Van Der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 1988;18:317-21.
19. Gianninni D, Garletti A, Dente FL, et al. Tolerance to salmeterol in allergen induced bronchoconstriction. Chest 1996;110:1452-7.
20. Ramage L, Lipworth BS, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8.
21. Simons FER, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997;99:655-9.